Cohance Lifesciences Executive and Leadership Team

November, 2026

Leadership Overview

Cohance Lifesciences has 4 executives leading key functions including corporate strategy, API and formulation development, platform operations, and technology manufacturing.

Focused on accelerating pharmaceutical innovation through advanced CDMO services, Cohance Lifesciences delivers integrated solutions for complex molecule development while maintaining a steadfast commitment to global sustainability and quality standards.

Leadership Roles at Cohance Lifesciences

  • Executive Chairman & Global Chief Executive Officer - Umang Vohra
  • Chief Executive Officer, Api Plus (Api & Formulations) - Gunjan Singh
  • Chief Operating Officer, Platform - Ravinath Shetty
  • Chief Operating Officer, Technology Operations - Sunil Uttarwar
  • Umang Vohra - Executive Chairman & Global Chief Executive Officer

    Umang Vohra, the Executive Chairman & Global Chief Executive Officer at Cohance Lifesciences, directs the overarching corporate strategy and long-term vision for the organization. Overseeing global market expansion, the Executive Chairman & Global Chief Executive Officer ensures alignment between internal development capabilities and the evolving needs of pharmaceutical innovators. This leadership role involves managing high-level partnerships and driving the company toward commercial scale in the competitive CDMO landscape. By prioritizing sustainable growth and operational excellence, Umang Vohra directly impacts the trajectory of the business. Through rigorous oversight of international operations, the Executive Chairman & Global Chief Executive Officer secures the firm's position as a leader in Antibody Drug Conjugates and Small Molecules. Ultimately, Vohra maintains the integrity of the global pipeline while fostering innovation across all clinical analytical service divisions.
    Umang Vohra

    Gunjan Singh - Chief Executive Officer, Api Plus (Api & Formulations)

    Gunjan Singh, the Chief Executive Officer, Api Plus (Api & Formulations) at Cohance Lifesciences, manages the end-to-end development and manufacturing of active pharmaceutical ingredients and complex formulations. Overseeing the API division, the Chief Executive Officer, Api Plus (Api & Formulations) ensures that all production processes meet stringent quality benchmarks for global clients. This leadership role involves scaling manufacturing capacity to support pharmaceutical innovators from discovery through commercialization. By optimizing chemical synthesis workflows, Gunjan Singh directly influences the efficiency of the drug development pipeline. Through strategic coordination with internal research teams, the Chief Executive Officer, Api Plus (Api & Formulations) drives the adoption of advanced manufacturing techniques. Ultimately, Singh secures the company's reputation for excellence in small molecule production and formulation services across diverse international markets.

    Ravinath Shetty - Chief Operating Officer, Platform

    Ravinath Shetty, the Chief Operating Officer, Platform at Cohance Lifesciences, architects the operational framework supporting the company's specialized CDMO service offerings. Overseeing the integration of Nucleic Acid Chemistry and ADC platforms, the Chief Operating Officer, Platform ensures seamless execution of complex development projects. This leadership role involves streamlining cross-functional workflows to enhance service delivery speed for pharmaceutical partners. By refining the operational infrastructure, Ravinath Shetty directly impacts the scalability of the firm's technical capabilities. Through constant monitoring of platform performance, the Chief Operating Officer, Platform maintains high standards of precision in clinical analytical services. Ultimately, Shetty drives the operational efficiency required to support the company's mission of accelerating the pipeline for innovators, ensuring that all platform-based initiatives align with broader corporate objectives and market demands.
    Ravinath Shetty

    Sunil Uttarwar - Chief Operating Officer, Technology Operations

    Sunil Uttarwar, the Chief Operating Officer, Technology Operations at Cohance Lifesciences, directs the technical manufacturing infrastructure and facility management across the organization. Overseeing the implementation of advanced manufacturing technologies, the Chief Operating Officer, Technology Operations ensures that all production sites maintain peak operational readiness and compliance. This leadership role involves managing the transition of complex molecules from laboratory settings to large-scale commercial manufacturing. By optimizing facility throughput and resource allocation, Sunil Uttarwar directly supports the company's commitment to quality and sustainability. Through the modernization of technical systems, the Chief Operating Officer, Technology Operations enhances the firm's ability to handle intricate chemical processes. Ultimately, Uttarwar secures the reliability of the supply chain, ensuring that all technology-driven operations meet the rigorous requirements of global pharmaceutical clients.
    Sunil Uttarwar

    Explore Leadership Teams in Manufacturing

    Frequently Asked Questions Regarding Cohance Lifesciences Top Executives and Leadership Team

    Who leads Cohance Lifesciences?
    Cohance Lifesciences is led by Umang Vohra (Executive Chairman & Global Chief Executive Officer), along with executives such as Gunjan Singh (Chief Executive Officer, Api Plus (Api & Formulations)) and Ravinath Shetty (Chief Operating Officer, Platform).
    Who is part of Cohance Lifesciences’s executive team?
    The executive team of Cohance Lifesciences includes leaders such as Umang Vohra (Executive Chairman & Global Chief Executive Officer), Gunjan Singh (Chief Executive Officer, Api Plus (Api & Formulations)), Ravinath Shetty (Chief Operating Officer, Platform) and other senior executives.
    How many executives does Cohance Lifesciences have?
    Cohance Lifesciences has 4 executives leading key business areas.
    What roles are included in Cohance Lifesciences’s leadership team?
    The leadership team of Cohance Lifesciences includes roles such as Executive Chairman & Global Chief Executive Officer, Chief Executive Officer, Api Plus (Api & Formulations), Chief Operating Officer, Platform, Chief Operating Officer, Technology Operations.